Helen Tosch, who worked with Indegene, Inc., from October 2020 till January 2023 as Principal Consultant, Digital Strategy has filed three charge claims on October 27, 2023 against Indegene, Inc. with the Illinois Department of Human Rights alleging: (1) wrongful termination due to her age and gender; (2) discrimination under the American Disabilities Act (ADA) and Family Medical Leave Act (FMLA); and (3) failure to rehire. Dening these allegations, Indegene, Inc. has asserted that she was terminated due to lack of work, unrelated to her need for FMLA time, age, or gender.
Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired By Renowned Global Biopharma Leader Jill DeSimone
Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy
Everest Group recognizes Indegene as a Leader in Life Sciences Digital Services Specialist PEAK Matrix® Assessment 2024
HFS Research recognizes Indegene as a Market Leader in the HFS Horizons: Life Sciences Service Providers, 2023 report
PRINCETON, N.J., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, announced the fifth edition of Indegene Digital Summit, the annual flagship...
PRINCETON, N.J. and ISRAEL, May 24, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company announced today that it will be expanding its partnership with ConTIPI...
PRINCETON, N.J. and SINGAPORE, May 16, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, announced today that it is joining hands with SynPhNe, to bring...
PRINCETON, N.J., April 06, 2023 (GLOBE NEWSWIRE) -- Everest Group recognizes Indegene, a digital-first, life sciences commercialization company, as a Leader in its Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023. Everest Group acknowledged Indegene’s long-term vision, robust capabilities, and sustained market impact as key factors for this recognition. nn“The next few years will be dynamic for the life sciences industry due to the interplay of macroeconomic, geopolitical, and regulatory developments. To ensure competitive differentiation, robust yet agile sales and marketing operations will be critical. Increased collaboration of life sciences enterprises with service providers will help achieve this differentiation,” said Abhishek A K, Practice Director at Everest Group. “Indegene’s robust suite of offerings in the commercial segment, technology investments, and strong brand recall, combined with domain expertise helped to position it as a Leader on Everest Group’s Life Sciences Sales and Marketing Operations - Services PEAK Matrix® Assessment 2023.” nn“With our exclusive focus on life sciences, we bring a practitioner’s perspective to life sciences companies, helping solve the industry’s most complex problems, advance patient-centric care, and aid better health across the world. We will remain focused on helping our clients modernize and personalize their sales and marketing efforts with a digital-first approach, and enable superior commercial outcomes,” said Vivek Ghai, Executive Vice President of Enterprise Commercial Solutions at Indegene. “This recognition validates our vision of driving personalized customer experience at scale, via an omnichannel approach, and our proven track record in helping life sciences companies be future-ready.”